Oramed Pharmaceuticals Inc. (TLV: ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 840.60
-11.10 (-1.30%)
Jan 19, 2025, 3:49 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 329.39 million as of January 22, 2025. Its market cap has decreased by -6.58% in one year.
Market Cap
329.39M
Enterprise Value
-180.18M
Revenue
n/a
Ranking
n/a
PE Ratio
19.85
Stock Price
840.60
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 329.39M, an increase of 13,790.52%. That is a compound annual growth rate of 26.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 88.56B |
| Danel (Adir Yeoshua) | 2.55B |
| Kamada | 1.47B |
| Bait Bakfar | 1.05B |
| Novolog (Pharm-Up 1966) | 965.26M |
| Ilex Medical | 870.07M |
| BrainsWay | 694.21M |
| SofWave Medical | 608.67M |